Vysioneer Named a Finalist in the 2026 Fierce Life Sciences Innovation Awards!

We're proud to announce that Vysioneer's VTrial has been selected as a finalist in the Data Analytics/Business Intelligence category of the 2026 Fierce Life Sciences Innovation Awards!

VTrial serves as AI infrastructure for oncology clinical development, providing both AI-powered RECIST and advanced biomarker analytics to transform clinical trial data into richer, more actionable efficacy insights.

Our mission is to support oncology drug developers in making informed decisions earlier in clinical development, ultimately bringing effective cancer treatments to patients faster.

We're excited to see our work recognized and grateful to our team, collaborators, and partners who have helped bring this innovation into real-world clinical trials.

Thank you to Fierce Life Sciences Events for this recognition!